How insecticides and temperature affect the spread of dengue virus by mosquitoes
Official title: Impact of insecticide control measures and temperature on Dengue Virus transmission by Aedes aegypti mosquitoes
Funded at University of Notre Dame · NIH-10900909 · Data updated 2026-11-12
This study looks at how temperature and the use of insecticides affect the spread of dengue virus by mosquitoes, aiming to find better ways to prevent dengue outbreaks and help keep you and your community safe.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Notre Dame NIH-funded |
| Lab location | 1 site (Notre Dame, United States) |
| Project start | August 15, 2024 |
| Project end | August 14, 2026 |
| Funding year | 2024 |
| Award (this year) | $48,974 |
| NIH project number | 1F31AI183638-01 |
| Project ID | NIH-10900909 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in regions where dengue is prevalent, particularly those who may be at risk of infection due to environmental factors.
✕Less likely to help
Patients who live in areas where dengue is not endemic or who are not at risk of exposure to Aedes aegypti mosquitoes may not benefit from this research.
What this research studies
This research investigates how temperature and insecticide use influence the transmission of the dengue virus by Aedes aegypti mosquitoes. By developing predictive models that incorporate both temperature and insecticide effects, the study aims to better understand and mitigate the risks associated with dengue outbreaks. The approach involves analyzing the interaction between these factors and their impact on mosquito behavior and virus transmission rates. Patients can benefit from improved strategies to control dengue transmission, potentially leading to reduced incidence of the disease.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for controlling dengue virus transmission, ultimately reducing the number of cases and deaths associated with the disease.
How similar studies have gone: Previous research has shown success in using predictive models to understand mosquito-borne disease transmission, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
University of Notre Dame
Notre Dame, United States Active
Researchers
- Principal investigator: Heffernan, Patrick — University of Notre Dame
- Study coordinator: Heffernan, Patrick
Related research
Other NIH-funded projects on the same topics.
-
Immune responses linked to severe dengue in children (primary infection)
This grant studies why some kids get very sick from their first dengue infection and how their immune system reacts differently from secondary infections.
-
Phase 2b trial of dengue vaccines TAK-003 and Butantan-DV to boost lasting, broad antibody protection
A trial tests whether giving a second dengue vaccine (Butantan-DV) after an initial TAK-003 shot can create stronger, longer-lasting antibodies that work against all dengue types.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Selective GAK inhibitors to fight dengue, VEEV and other emerging viral infections
A Stanford team is testing new, selective inhibitors of GAK to block how certain viruses enter and exit cells, with the goal of a broad antiviral approach that could help people exposed to dengue, VEEV, and similar infections.
-
Defining immune markers predicting protection against dengue in a long-term family study in Thailand
This grant looks at how antibodies develop to protect against dengue in children from a long-running family cohort in Thailand, with the goal of identifying immune signs that predict protection across multiple dengue serotypes.
-
Understanding dengue protection in children from a long-term Thai family cohort
A long-term study in Thailand follows families to understand how early exposures to dengue shape protection and illness risk for children as they encounter the virus over time.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.